Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Nov 7;10(21):5194.
doi: 10.3390/jcm10215194.

Relationship between Adipokines and Cardiovascular Ultrasound Parameters in Metabolic-Dysfunction-Associated Fatty Liver Disease

Abdulrahman Ismaiel  1 , Mihail Spinu  2 , Livia Budisan  3 , Daniel-Corneliu Leucuta  4 , Stefan-Lucian Popa  1 , Bogdan Augustin Chis  1 , Ioana Berindan-Neagoe  3   5   6 , Dan Mircea Olinic  2   7 , Dan L Dumitrascu  1
Affiliations

Relationship between Adipokines and Cardiovascular Ultrasound Parameters in Metabolic-Dysfunction-Associated Fatty Liver Disease

Abdulrahman Ismaiel et al. J Clin Med. .

Abstract

(1) Background: The role of adipokines such as adiponectin and visfatin in metabolic-dysfunction-associated fatty liver disease (MAFLD) and cardiovascular disease remains unclear. Therefore, we aim to assess serum adiponectin and visfatin levels in MAFLD patients and associated cardiovascular parameters. (2) Methods: A cross-sectional study involving 80 participants (40 MAFLD patients, 40 controls), recruited between January and September 2020, was conducted, using both hepatic ultrasonography and SteatoTestTM to evaluate hepatic steatosis. Echocardiographic and Doppler parameters were assessed. Serum adipokines were measured using ELISA kits. (3) Results: Adiponectin and visfatin levels were not significantly different in MAFLD vs. controls. Visfatin was associated with mean carotid intima-media thickness (p-value = 0.047), while adiponectin was associated with left ventricular ejection fraction (LVEF) (p-value = 0.039) and E/A ratio (p-value = 0.002) in controls. The association between adiponectin and E/A ratio was significant in the univariate analysis at 95% CI (0.0049-0.1331, p-value = 0.035), but lost significance after the multivariate analysis. Although LVEF was not associated with adiponectin in the univariate analysis, significant values were observed after the multivariate analysis (95% CI (-1.83--0.22, p-value = 0.015)). (4) Conclusions: No significant difference in serum adiponectin and visfatin levels in MAFLD patients vs. controls was found. Interestingly, although adiponectin levels were not associated with LVEF in the univariate analysis, a significant inversely proportional association was observed after the multivariate analysis.

Keywords: SteatoTest; adipokines; adiponectin; cardiovascular disease; hepatic steatosis; metabolic-dysfunction-associated fatty liver disease (MAFLD); visfatin.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
Flow diagram outlining the enrollment process of included and excluded participants.
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Dumitrascu D.L., Neuman M.G. Non-alcoholic fatty liver disease: An update on diagnosis. Clujul Med. 2018;91:147–150. doi: 10.15386/cjmed-993. - DOI - PMC - PubMed
    1. Sporea I., Popescu A., Dumitrașcu D., Brisc C., Nedelcu L., Trifan A., Gheorghe L., Braticevici C.F. Nonalcoholic Fatty Liver Disease: Status Quo. J. Gastrointest. Liver Dis. 2018;27:439–448. doi: 10.15403/jgld.2014.1121.274.quo. - DOI - PubMed
    1. Mantovani A., Scorletti E., Mosca A., Alisi A., Byrne C.D., Targher G. Complications, morbidity and mortality of nonalcoholic fatty liver disease. Metabolism. 2020;111:154170. doi: 10.1016/j.metabol.2020.154170. - DOI - PubMed
    1. Francque S.M., van der Graaff D., Kwanten W. Non-alcoholic fatty liver disease and cardiovascular risk: Pathophysiological mechanisms and implications. J. Hepatol. 2016;65:425–443. doi: 10.1016/j.jhep.2016.04.005. - DOI - PubMed
    1. Mirza M.S. Obesity, Visceral Fat, and NAFLD: Querying the Role of Adipokines in the Progression of Nonalcoholic Fatty Liver Disease. ISRN Gastroenterol. 2011;2011:592404. doi: 10.5402/2011/592404. - DOI - PMC - PubMed

LinkOut - more resources